| Gene symbol | RNR2 | Synonyms | MTRNR2 | Type of gene | rRNA |
| Chromosome | MT | Map location | - | dbXrefs | |
| Description | l-rRNA | ||||
| GTO ID | GTC1201 |
| Trial ID | NCT00056173 |
| Disease | Renal Cell Carcinoma |
| Altered gene | RNR2 |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | GTI-2040 |
| Co-treatment | capecitabine |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | A Phase I/II Study of GTI-2040 and Capecitabine Combination Therapy in Patients With Advanced or Metastatic Renal Cell Carcinoma (mRCC) |
| Year | 2002 |
| Country | United States |
| Company sponsor | Aptose Biosciences Inc. |
| Other ID(s) | L01-1409 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||